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Angiopoietin-2The tumor suppressor Pdcd4 is involved in multiple pathways. Considering its biological action conﬂicting
data in the literature exist and, consequently, our own studies point to a cell type speciﬁc action of Pdcd4.
In the present study, using several Pdcd4 knock down cell lines we succeeded to identify angiopoietin-2
(Ang-2) as a gene up-regulated on the mRNA and protein level. The subsequent enhanced peptide secretion
forced wild type Bon-1 cells in a neoplastic direction demonstrated by increased proliferation and colony for-
mation while cell adhesion was decreased. Most likely, the stimulation of Ang-2 is in part mediated by in-
creased activation of AP-1 but different signal transduction pathways may also be involved since we found
opposite activation of PI3K/Akt/mTOR and MAPK7ERK pathways (both known to regulate in Ang-2 expres-
sion). Ang-2 is a modulator of vascular remodeling. Therefore, we analyzed the effect of supernatants from
Pdcd4 knock-down cell lines on endothelial cells. Again, we detected reduced cell adhesion and increased
colony formation. Probably, the most impressive effect was described on tube formation in a model for angio-
genesis. Tube length and junctions of endothelial cells treated with conditioned medium from Pdcd4 knock-
down cells were considerably increased. Both, up-regulation of Ang-2 and down-regulation of Pdcd4 are de-
scribed for many tumors. However, this is the ﬁrst study showing a direct impact of Pdcd4 on Ang-2 levels
and, thereby, angiogenesis. Our data suggest a completely new mechanism for Pdcd4 to act as a tumor sup-
pressor rendering Pdcd4 an attractive target for new therapeutic strategies in cancer treatment.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Pdcd4 (programmed cell death 4) is a well established tumor sup-
pressor and is regulated by different pathways (for review [1]).
Meanwhile, it became clear that miR-21 (microRNA-21) is a major
regulator of Pdcd4 and, to date, numerous publications describe the
inverse correlation of Pdcd4 and miR-21 levels with an increase of
miR-21 and a decrease of Pdcd4 in a wide variety of tumors (for re-
view see [2, 3]). The protein contains two α-helical MA-3 domains
mediating binding of Pdcd4 to the RNA helicase eIF4A, thereby inhi-
biting helicase activity and subsequently translation [4]. Consistently,
translational repression was demonstrated for carbonic anhydrase II
and IL-10 [5, 6]. Further target molecules of Pdcd4 involved in cell
cycle progression, proliferation and invasion were identiﬁed on a pre-
translational level such as HPK1 (hematopoietic progenitor kinase 1),
uPAR (urokinase receptor), and dUTPase [7-9]. Additionally, secretion
of TIMP-2 (tissue inhibitor of metalloproteinase-2), chromogranin A
and secretogranin II [10, 11] was shown to be affected by Pdcd4 levels
in different cell lines (for review see [1]). Pdcd4 acts via multiple: +49 6421 5862156.
ankat-Buttgereit).
rights reserved.signal, transduction pathways. However, conﬂicting data exist
depending on the cell lines used.
In a neuroendocrine cell line elevated levels of Pdcd4 induced
p21Waf1/Cip1 [12]. In contrast to these data the knockdown of Pdcd4
just as well induced p21Waf1/Cip1 in HeLa and HCT116 cells [13], while
in AML (acute myeloid leukemia) cells reduced Pdcd4 levels did not
alter p21Waf1/Cip1 [14]. These ﬁndings are well in line with other data
showing no correlation of Pdcd4 levels and the expression of different
proteins associated with cell cycle and apoptosis in various tumor cell
lines [7]. Moreover, for several proteins opposite effects mediated by
Pdcd4 were found in the neuroendocrine Bon-1 and the colon carcino-
ma HCT116 cell lines stably over-expressing Pdcd4 including dUTPase,
pMEK1/2, caspases 3, 7 and 10, cdc2 and p21Waf1/Cip1 [7]. These data
suggest to a cell-type speciﬁc action of Pdcd4. Therefore, we performed
a cDNA microarray analysis with RNA from stably transfected shPdcd4
(knockdown) Bon-1 and HCT116 cell lines in comparison to RNA from
mock transfected cells. Interestingly, in both cell lineswe found a signif-
icant increase of angiopoietin-2 (Ang-2) mRNA while levels of Pdcd4
are clearly reduced. The angiopoietin family of growth factorswas iden-
tiﬁed around 1995 (for review see [15]). Four members are known:
angiopoietins 1 to 4. The best characterized proteins are Ang-1 and
Ang-2 and these proteins have a role in blood vessel formation. Angio-
poietins are secreted glycosylated proteins with a molecular weight of
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Tie2 receptor, but only Ang-1 binding induces autophosphorylation and
activation of the receptor [16]. Ang-2 acts as an antagonistic ligand and
inhibits Ang-1/Tie2 signaling [17]. However, other data showed an ago-
nistic function of Ang-2 [18, 19]. Tie2 activation promotes vessel assem-
bly and maturation (for review see [15]) and Tie2 deﬁcient mice die
early at E10.5 due to vessel remodeling defects [20, 21]. In a similar
manner, Ang-1 deﬁciency inmice leads to death at E11–E12.5 due to se-
vere vascular defects [21]. For Ang-2 deﬁcient mice the lethality seems
to depend on the genetic background [22, 23]. Surviving mice show
minor defects, but disorganized lymphatic vessels. These contradictory
results may reﬂect a dual role of Ang-2 during remodeling and vascular
regression during physiological and pathological processes. In the pres-
ence of VEGF, Ang-2 induces angiogenesis, whereas in the absence of
VEGF vessel regression is triggered (for review see [24]). In addition,
Ang-2 is strongly expressed in many tumors and may promote tumor
associated vascularization. Moreover, elevated levels of Ang-2 were
detected in the circulation of cancer patients and possibly the increase
in Ang-2 concentration correlates with tumor progression (for review
see [25]).
In this study, we evaluated the regulation of Ang-2 by Pdcd4
knock-down in different cell lines and the implications of elevated
Ang-2 concentrations on endothelial and tumor cells.
2. Materials and methods
2.1. Cell culture
All media contained 10% fetal bovine serum and 40 μg/ml genta-
micin. All cell lines were from human origin and cultured in the indi-
cated media. Bon-1 carcinoid [26], Hek293 embryonic kidney cells:
DMEM/HAM's F12 medium; HCT116 colon carcinoma, HT29 colorec-
tal adenocarcinoma cells: McCoy's 5A medium; HepG2 hepatocellular
carcinoma cells: RPMI1640 medium; MCF-7 breast adenocarcinoma
cells: RPMI1640 with 1 mM sodium pyruvate, 1× non essential
amino acids and 10 μM insulin; Capan-1 pancreatic adenocarcinoma
from metastatic site liver, Imim PC1 pancreatic adenocarcinoma
(courtesy of Prof. Paco Real, CNIO, Madrid, Spain), MDA-231 ductal
breast adenocarcinoma, Panc-1 pancreatic adenocarcinoma and Pa-
Tu8988T pancreatic adenocarcinoma cells from metastatic site
liver (courtesy of Prof. H.-P. Elsässer, Department of Cytobiology,
Philipps-University, Marburg, Germany): DMEM High Glucose with
L-Glutamine; HMEC-1 immortalized microvascular endothelial cells
(courtesy of PD Dr. R. Köhler, Department of Internal Medicine—
Nephrology, Philpps-University, Marburg, Germany [27]): DMEM
High Glucose with L-Glutamine and 1 mM sodium pyruvate. Capan-1,
HCT116, Hek293, Hep G2, HT29, MCF-7, MDA-231 and Panc-1 cells
were purchased from ATCC. Cell number was analyzed by counting
the cells in a Neubauer chamber. Conditioned media were obtained
from stably shPdcd4 transfected HCT116 and Bon-1 cells cultured for
3 days to a conﬂuency of about 70%. The amount of medium used for
these experiments was sufﬁcient for growth of the cells for 9–10 days,
therefore, enough nutrients should be left to ensure growth of other
cells for several days. HCT116 cells showed no alteration in growth by
transfection with shPdcd4 and the 20% increase in growth of shPdcd4
Bon-1 cells at day 3 was adjusted by plating different densities.
2.2. Transfections, MTT-assay, Western Blot and antibodies
Stably shPdcd4 transfected Bon-1 and HCT116 cells, transient
transfections, MTT-assays, protein extraction, Western Blots and
immunodetection were performed as described in Lankat-Buttgereit
et al. [10]. Down-regulated expression of Pdcd4 and Ang-2 was con-
ﬁrmed by Western Blotting using an antibody directed against
Pdcd4 [7]. Polyclonal antibodies to Ang-2 were from Alpha Diagnostic
International, USA, antibodies directed against Akt, pAkt, pMek1/2and c-jun were from Cell Signaling, pErk1/2, pc-jun and actin-HRP an-
tibodies from Santa Cruz. Transient transfections for knockdown of
Ang-2 were performed with 3 different FlexiTube siRNAs (Qiagen,
Germany).2.3. RNA isolation, microarray analysis and semi-quantitative RT-PCR
Total RNA isolation, microarray analysis with the Human Genome
Survey Microarray V2.0 and semiquantitative RT-PCR were per-
formed as described in Lankat-Buttgereit et al. [10]. Primers for am-
pliﬁcation of Ang-2 were synthesized yielding a 274 bp product
(Ang-2 sense: GTC CAA TGC TGT GCA GAG GGA CG; Ang-2 antisense:
CTG ATT TAA TAC TTG GGC TTC CAC). As an internal control β- actin
primers were used yielding a 332 bp product (actin sense: AGG CCA
ACC GCG AGA AGA TGA CC; actin antisense:GAA GTC CAG GGC GAC
GTA GCA C). After 40 cycles, aliquots from each sample were removed
and analyzed on a 2% (w/v) agarose gel.2.4. Tube formation assays
BD Matrigel™Basement Membrane Matrix Growth Factor Re-
duced (BD Bioscience) was thawed and plated according to the sup-
plier's protocol. 20,000 HMEC-1 cells suspended in the appropriate
conditioned media or media containing recombinant Ang-2 (Biomol,
Germany), respectively, were plated onto the Matrigel. After an incu-
bation for 18 h at 37 °C the wells were photographed at a 4× magni-
ﬁcation with a Canon 450 EOS camera connected to the microscope
(Olympus IMT2). Length and junctions of the generated tubes were
analyzed with the TimeLapseAnalyzer program [28]. Each experiment
was performed in duplicates and repeated twice with at least 4 inde-
pendently obtained conditioned media.2.5. Cell migration and wound healing experiments
Cell migration and wound healing were performed as described
previously [29]. Brieﬂy, 40,000 cells in 500 μl per inset of a 24-well
plate were used and incubated for 4 h. Insets were then rinsed with
PBS, dried at room temperature and ﬁxed with methanol. Migration
was measured by counting 10 ﬁelds of view under a microscope cov-
ering about 70–80% of the inset area of the ﬁxed and stained cells
(0.2% crystal violet) migrating towards the conditioned media and
normalized to the number of migrated cells towards mock condi-
tioned media. For wound healing cells were plated in 12 well plates
and grown to 90% conﬂuency. For 3 h 10 μg/ml mitomycin was
added to inhibit proliferation. A linear scratch wound was made on
the plate, cells were rinsed with PBS and conditioned media were
added. The cells were incubated at 37 °C and 5% CO2 under a Zeiss
Axiovert 200M for 24 h. The ratio cell/wound was calculated using
the TimeLapseAnalyzer program [28]. Each experiment was per-
formed in duplicates and repeated twice. At least 3 different indepen-
dently obtained conditioned media were used for each experiment.2.6. Adhesion assays
Adhesion assays were performed as described earlier [30]. Brieﬂy,
conditioned media were added to 12 well plates and incubated at 4 °C
for 24 h. Media were removed and 1% BSA was added for 1 h at 4 °C to
block unspeciﬁc binding. After removal of the BSA 80,000 cells were
plated and incubated for 2 h at 37 °C. Unadherent cells were removed
by repeated washing with PBS and ﬁnger tapping to agitate the wells.
Adherent cells were stained with MTT. Each experiment was per-
formed in duplicates and repeated twice. At least 3 different indepen-
dently obtained conditioned media were used for each experiment.
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Colony formation assays were performed as described in Buchholz
et al. [31]. Per well 10,000 cells were suspended in 0.7 ml conditioned
media, 50 μl 5% bacto-agar was added, plated and incubated at 37 °C
for 10 days. Colonies containing more than 5 cells were counted in
an Olympus IMT-2 microscope and averaged over 10 ﬁelds of view.
Each experiment was performed in duplicates and repeated twice.
At least 3 different independently obtained conditioned media were
used for each experiment. Approximately 4000 colonies for Bon-1
and 800 colonies for HMEC-1 cells were formed per 10,000 cells.
2.8. Statistics
All data is presented asmean±standard error. Two tailed paired Stu-
dent's t test was used for statistical evaluation of the data. A p value b0.05
was considered signiﬁcant.
3. Results
3.1. Knockdown of Pdcd4 enhances Ang-2 expression
In order to further elucidate the role of Pdcd4, we stably knocked-
down Pdcd4 in two cell lines, neuroendocrine Bon-1 and colorectal
carcinoma HCT116 cells, by transfection with shPdcd4 plasmid as de-
scribed earlier [10] and isolated RNA from at least two different
clones each. With this RNA we performed cDNA microarray analysis
using the Human Genome Survey Microarray V2.0 (32,878 probes
for detection of more than 27,000 genes) in comparison to RNA
from mock-transfected cells (see supplemental material). Whereas
only a small number of similar deregulated genes in both cell systemsHCT116
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Fig. 1. Regulation of Ang-2 by reduced Pdcd4 levels. A: Semi-quantitative RT-PCR of RNA obt
parison to mock transfected cells (mock). Actin ampliﬁcation served as an internal control f
induction of Ang-2 (Ang-2) protein levels Western Blot analysis was used. Actin served as a
siently shPdcd4 and siPdcd4 transfected cell lines.were uncovered by microarray analysis, we detected a prominent in-
crease in Ang-2 mRNA in both stably shPdcd4 transfected cell lines.
The expression of other molecules involved in vascular remodeling
like VEGF-A and Ang-1 remained unchanged in Bon-1 cells and even
decreased in HCT 116 cells (−1.6 for Ang-1 and −2.6 for VEGF-A,
data not shown). Consistent with this data, over-expression of
Pdcd4 slightly reduced Ang-2 (0.9 for HCT116 and 0.6 for Bon-1
cells), induced levels of Ang-1 (1.38 in HCT116 and 4.9 in Bon-1
cells) and revealed slightly higher values for VEGF-A (1.9 and 1.8)
in microarray analysis (MWG Biotech, Germany, data not shown).
To verify the data concerning Ang-2 on the RNA level as well as on
the protein level, we transiently transfected the corresponding wild
type cell lines (Bon-1 and HCT116) with siPdcd4-RNA and compared
the results with the data obtained from two stably transfected clones
to exclude integration artifacts. After isolation of RNA and protein,
semi-quantitative RT-PCR and Western Blot were performed. Semi-
quantitative RT-PCR demonstrated the increased amounts of Ang-2
mRNA in cells with reduced Pdcd4 expression (Fig. 1A). The knock-
down of Pdcd4 in stably as well as in transiently transfected cell
lines was proven by Western Blot (Fig. 1B). Furthermore, the in-
creased Ang-2 mRNA levels were reﬂected by elevated Ang-2 protein
amounts in both cell lines (Fig. 1B). An opposed effect was observed
by over-expression of Pdcd4 in Bon-1 and HCT116 cells: Ang-2 was
down-regulated demonstrated by microarray analysis (see above)
and Western Blot analysis (supplemental Fig. 1A and 1B) of stably
transfected cell lines [7]. The weakened effect in comparison to
knockdown cell lines is most probably due to endogenous levels of
Pdcd4 which was a reason to change to knockdown cell lines.
Since we had found a similar regulation of a protein by Pdcd4
levels in Bon-1 and HCT116 cells for the ﬁrst time, we investigated
Ang-2 levels in a variety of other cell lines transiently transfectedActin 332 bp
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ained from stably and transiently transfected HCT116 and Bon-1 cells (siPdcd4) in com-
or equal RNA amounts as templates. B: To verify the knockdown of Pdcd4 (Pdcd4) and
control for equal protein loading. mock: mock transfected cells; siPdcd4: stably or tran-
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siPdcd4 transfected cells in comparison to mock transfected cells by
Western Blot (Fig. 2). Additionally, Ang-2 expression was analyzed
on the same blots. Even though the Pdcd4 levels were rather low in
some cell lines (Panc-1, Hep G2 and MDA-231) and hard to verify
byWestern Blot, elevated Ang-2 protein amounts in transiently trans-
fected cells could be detected. For some selected cell lines semi-
quantitative RT-PCR were conducted to verify the Ang-2 regulation
at the mRNA level (Fig. 3A). In every case reduced Pdcd4 levels
resulted in increased Ang-2 expression. Digital quantiﬁcation of the
signals of at least 3 independent experiments showed a signiﬁcant 3
to 19-fold increase of Ang-2 mRNA in almost all cell lines (Fig. 3B).
To conﬁrm that the enhanced expression of Ang-2 resulted in in-
creased secretion we performed Western Blot analysis of the super-
natants of stably (HCT116, Bon-1) siPdcd4 transfected cell lines
(Fig. 2 in supplement). A clearly intensiﬁed signal is visible for Ang-
2 in the medium of shPdcd4 transfected Bon-1 as well as HCT116
cells in comparison to mock transfected cells, pointing to an enhanced
release of the protein. No quantiﬁcation was performed since the dif-
ferent cell lines release different amounts of Ang-2 (the neuroendo-
crine cell line Bon-1 can secrete higher amounts than the colon
carcinoma cell line HCT116, clearly visible in supplemental Fig. 2).
The change in relative levels of Ang-2 is crucial for the question
addressed in these experiments.
Ang-2 expression is induced at least in part via AP-1 [32]. Since
Pdcd4 inﬂuences AP-1 transactivation, we investigated the effect of
Pdcd4 levels on activation of c-jun. Whereas we found inconsistentImimPC1
Panc1
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Fig. 2. Regulation of Ang-2 by reduced Pdcd4 levels in different transiently siPdcd4
transfected cell lines. Western Blot with Pdcd4 antibody (Pdcd4) was used to verify
Pdcd4 knockdown (siPdcd4) in comparison to mock transfected cells (mock). An in-
crease of Ang-2 was found in every cell line. At least 3 independent transient transfec-
tions were performed for each cell line and representative experiments are shown.
Actin served as a control for equal protein loading.results for c-jun proteins levels in stably transfected cell lines (sup-
plemental Fig.1A), an increase in phosphorylated c-jun is found in
both Pdcd4 knockdown Bon-1 and HCT116 cells (digital scan in sup-
plemental Fig. 1B). Therefore, activation of AP-1 is one probable
mechanism for increased expression of Ang-2 in different cell lines.
However, Ang-2 expression and secretion are regulated by multiple
stimuli activating different signal transduction pathways [33]. One
of these is the MAPK/ERK pathway. In human breast cancer cells
and endothelial cells ERK kinase activity regulates Ang-2 expression
[32, 34]. This mechanism seems unlikely for all cell types since by
knock-down of Pdcd4 in Bon-1 and HCT116 cells we found no regula-
tion of pERK1/2 and opposite effects on pMEK1/2 and c-jun ([7, 10]
and supplemental Fig. 2). Likewise, conﬂicting data exist concerning
the involvement of the PI3K/Akt/mTOR pathway in the regulation of
Ang-2. In endothelial cells an activation of Akt down-regulated Ang-2
whereas in breast cancer cells enhanced pAkt levels lead to an up-
regulation of Ang-2 [34, 35]. Consistent with these hints for a cell-type
dependent regulation of Ang-2 expression we found opposite effects
on pAkt levels bymodulating Pdcd4 in Bon-1 andHCT116 cells (supple-
mental Fig. 1A and 1B). Most likely, Ang-2 expression is regulated in a
cell-type speciﬁc manner.
3.2. Supernatant from shPdcd4 transfected Bon-1 cells stimulates
proliferation and colony formation of non-transfected wild type
Bon-1 cells while reducing cell adhesion
Loss of Pdcd4 results in an increased expression and secretion of
Ang-2 as well as of other peptides in Bon-1 cells [10]. In further ex-
periments, we tested if conditioned media can inﬂuence the non-
transfected neuroendocrine cell line Bon-1. Treatment of these cells
for 7 days with media obtained from shPdcd4 transfected Bon-1
cells showed a clear increase in proliferation in comparison to the
treatment with conditioned medium from mock-transfected cells
(Fig. 4A). Whereas only minor and non signiﬁcant effects could be
detected after 1 and 3 days, signiﬁcantly enhanced proliferation is
seen after 7 days. Viability of the cells seemed not to be inﬂuenced
since doubling times were comparable to Bon-1 cells growing in the
regular medium (data not shown).
Multiwell plates coated with conditioned medium served for ad-
hesion assays. Again, a clear effect of shPdcd4 conditioned medium
from transfected Bon-1 and HCT116 cells was observed: adhesion
was clearly reduced in comparison to medium from mock-
transfected cells (Fig. 4B). These experiments could also be performed
with conditioned medium from HCT116 also, since the cells can grow
in their optimal medium. The reduced cell adhesion in presence of
conditioned medium from shPdcd4 transfected cells may refer to an
augmented metastatic potential of the cells.
In addition, we found a small but signiﬁcant increase in colony for-
mation of wild type Bon-1 cells by application of conditionedmedium
in soft agar assays suggesting an enhanced carcinogenesis (Fig. 4C). In
wound healing experiments the effect of conditioned medium was
not signiﬁcantly depicted (p=0.163) but a tendency to faster closing
of the wound was visible (data not shown). All the experiments show
a clear effect of the conditioned medium on non-transfected wild
type Bon-1 cells.
3.3. Impact of conditioned medium from shPdcd4 transfected cells on the
endothelial cell line HMEC-1
Ang-2 is involved in angiogenesis and the effect of conditioned
medium from cells with reduced Pdcd4 levels should be most pro-
nounced on endothelial cells. As a model system, we utilized the en-
dothelial cell line HMEC-1 for different assays [27]. One of the most
important functions of endothelial cells is the generation of vessels.
Therefore, we established a tube formation assay in matrigel to inves-
tigate the inﬂuence of conditioned medium on the ability of
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tant from shPdcd4 transfected Bon-1 as well as HCT116 cells induced
tube formation (open arrows tubes, solid arrows junctions). Analysis
of the assays with the TimeLapseAnalyzer program (example in
Fig. 6A) from at least 7 independent experiments revealed a striking
increase in tube length and junctions (Fig. 6B). To verify that these ef-
fects were caused by Ang-2, tube formation assays were performed
with medium containing 50–100 ng Ang-2/ml (Fig. 5B). Again, an in-
crease in length and junctions of the tubes could be detected (Fig. 6C).
All these experiments were done with medium containing 10% FBS
since the function of Ang-2 depends on the presence of growth fac-
tors. To further prove that the effects observed are deﬁnitely due to
Ang-2, we transiently transfected the stably Pdcd4 knockdown
HCT116 cells with three different siRNAs directed against Ang-2, iso-
lated protein extracts and collected the supernatants of the cells two
days post transfection. Knockdown of Ang-2 was veriﬁed by Western
Blot (Fig. 7A). All three siRNAs resulted in a comparable decrease of
Ang-2 protein (data not shown). Again we performed tube formation
analysis and found that increased length and junctions of the tubes
were reversed by knockdown of Ang-2 (Fig. 7B and C). The smaller ef-
fect on tube formation in comparison to only stably transfected cell
lines is most probably due to the fact that the media were already col-
lected at day 2. Clearly, these results demonstrate the importance of
Pdcd4 for regulated angiogenesis and, thereby, for tumor progression.
Cell migration capability was examined with the Boyden Chamber
assay and just as well, migration of the endothelial cells increased sig-
niﬁcantly by use of shPdcd4 conditioned medium from Bon-1 and
HCT116 cells as attractant (Fig. 8A). The sole exception in signiﬁcance
was obtained with conditioned medium from shPdcd4 transfectedBon-1 cells containing 1% FBS (p=0.073). In general, the HMEC
cells grow poorly in medium containing 1% FBS or less most likely
explaining non signiﬁcant results. Clear results were obtained with
soft agar assays for the colony formation ability of HMEC-1 cells as
well. The number of colonies increased signiﬁcantly (pb0.05) by the
treatment of the cells with conditioned medium from shPdcd4 trans-
fected Bon-1 cells in comparison to mock-transfected cells (Fig. 8B).
For adhesion assays the cells were cultured in the appropriate me-
dium, and a reduced adhesion of the HMEC-1 cells could be observed
on multiwell plates coated with conditioned medium from both
shPdcd4 transfected Bon-1 and HCT116 cells in comparison to
mock-transfected cells (Fig. 8C). Though the effect was not signiﬁcant
at the 0.05 level (p=0.082 for Bon-1 and p=0.054 for HCT116 con-
ditioned medium) a tendency to reduced adhesion is visible. The
HMEC-1 cells adhered to the coated wells very fast (in 15 min or
less) which might explain the low signiﬁcance. Proliferation of the
endothelial cells determined using the MTT assay was induced at
day 3 but not to a signiﬁcant level (data not shown). Unfortunately,
the HMEC-1 cells started to die at day 2, probably due to the fact
that the cells were not cultured in the optimal medium, but in condi-
tioned medium obtained from transfected Bon-1 and HCT116 cells,
respectively. The same problem was observed for wound healing ex-
periments and no signiﬁcant results were obtained (data not shown).
4. Discussion
Tumor growth often requires vascular remodeling including ves-
sel regression and neovascularization and vascularization inﬂuences
the resistance of tumors to chemotherapeutic agents. Therefore, the
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signiﬁcant (p=0.07 and 0.15) after 7 days increased proliferation was signiﬁcant (p=0.012). B: Bon-1 cell adhesion is signiﬁcantly reduced to plates coated with the supernatant
from either Bon-1 of HCT116 cells transfected with shPdcd4 in comparison to mock transfected cells (pb0.05). C: Colony formation of Bon-1 cells in soft agar assays is signiﬁcantly
increased (pb0.05) by treatment with conditioned medium from shPdcd4 transfected Bon-1 cells. Stars (☆) indicate signiﬁcant p-values (pb0.05).
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therapies. Interestingly, Ang-2 of the angiopoietin family is strongly
expressed in the vasculature of many tumors (for review see [15]).
However, the role of Ang-2 in angiogenesis is complex since Ang-2
acts context dependent as an agonist or an antagonist of the Tie-2 re-
ceptor: in the presence of VEGF angiogenesis is induced, whereas an
opposite effect is observed in the absence of VEGF (for review see
[15]).
Pdcd4 was ﬁrst identiﬁed as a protein involved in apoptosis but
soon a function as a tumor suppressor emerged. There is evidence
that the effects of Pdcd4 are cell type speciﬁc [7]. In this study, we
identiﬁed Ang-2 to be regulated by Pdcd4 levels in many if not all
cell lines which might explain the tumor suppressor function of
Pdcd4 in a variety of tumors. In addition, we showed that the en-
hanced expression and secretion of Ang-2 by reduced Pdcd4 levels
can affect surrounding cells especially tube formation by endothelial
cells.
Data from earlier studies indicated that the function of Pdcd4 may
be cell type speciﬁc [7]. However, Pdcd4 acts as a tumor suppressor in
different tumor cells and is down-regulated in a wide variety of can-
cers (for review see [1]). In order to elucidate an overall function of
Pdcd4, we stably knocked-down Pdcd4 expression in Bon-1 and
HCT116 cells and performed a cDNA microarray analysis. The most
prominent regulated gene in both cell lines was identiﬁed as Ang-2,
whereas Ang-1 and VEGF-A were not inﬂuenced. The enhanced
Ang-2 expression was conﬁrmed on the RNA and protein level by
semi-quantitative RT-PCR andWestern Blot in two clones of each sta-
bly transfected cell line as well as in a variety of different transiently
siPdcd4 transfected cell lines. Moreover, we could show that the in-
creased expression of Ang-2 resulted in enhanced release of the pro-
tein. Noteworthy, we previously found that Pdcd4 levels regulatedsecretion of chromogranin A (CgA) and secretogranin II (Sg II) in
the neuroendocrine cell line Bon-1 via activation of the protein kinase
Akt [10]. These results may now be of special relevance since secreto-
neurin, a Sg II derived peptide acts as a proangiogenic cytokine [36].
The complex action of Pdcd4 is highlighted by the fact that CgA and
Sg II release is at least in part due to activation of Akt by low levels
of Pdcd4 in Bon-1 cells, whereas in HCT116 cells no regulation of
pAKT neither by over-expression of Pdcd4 [7] nor by silencing
Pdcd4 levels was found (supplemental Fig. 2). Interestingly, in lung
microvascular endothelial cells a stimulation of Ang-2 secretion is de-
scribed by inhibition of Akt [35] which is in contrast to our data in
Bon-1 cells showing enhanced Ang-2 release in combination with
raised levels of activated Akt by silencing Pdcd4. Therefore, Pdcd4 is
likely to regulate Ang-2 expression in Bon-1 cells by other mecha-
nisms than the Akt pathway. In accordance with a cell-type speciﬁc
regulation, in breast cancer cells human epidermal growth factor re-
ceptor 2 (HER2) activity correlated with Ang-2 expression and Akt ac-
tivity was necessary for the up-regulation of Ang-2 which is in
contrast to the data obtained in endothelial cells [34]. However,
these opposing results are in good agreement with our ﬁndings that
knock-down of Pdcd4 induced pAkt in Bon-1 cells and decreased
pAkt in HCT116 cells even though both cell lines showed increased
expression of Ang-2. Another mechanism for regulation of Ang-2 ex-
pression displays the MAPK/ERK pathway. Even if enhanced ERK ki-
nase activity resulted in stimulation of Ang-2 levels in breast cancer
and endothelial cells [32, 34] our data point to a cell-type dependent
regulation of Ang-2. We found no effects on the levels of pERK1/2 and
an opposite impact on pMEK1/2 and c-jun levels by modulating
Pdcd4 amounts in Bon-1 and HCT116 cells but an increased phos-
phorylation of c-jun providing a mechanism for enhanced Ang-2 ex-
pression in both HCT116 and Bon-1 cell lines. Therefore, stimulated
Conditioned medium from
Mock shPdcd4 transfected cells
Bon-1
HCT116
HMEC-1
Mock 100 ng/ml Ang-2
A
B
Fig. 5. A: Tube formation of HMEC-1 cells in matrigel upon treatment with conditioned medium from mock and shPdcd4 transfected Bon-1 and HCT116 cells. Photographs were
taken with 4× magniﬁcation. The open arrow indicates an example of a tube, the solid arrow of a junction. B: Addition of recombinant Ang-2 resulted in tube formation comparable
to treatment with shPdcd4 conditioned medium.
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creased Ang-2 levels by knockdown of Pdcd4. Anyhow, considering
the multiple stimuli inﬂuencing Ang-2 expression most likely differ-
ent pathways contribute to variable parts to the regulation of Ang-2.
In addition to regulation of Ang-2 we show that cells with deple-
tion of Pdcd4 secrete peptides affecting surrounding cells. This effect
is at least in part due to Ang-2 release. This is of particular interest for
the development of new therapeutic strategies ﬁghting neuroendo-
crine tumors which are often resistant to radiation and chemothera-
peutic agents especially since we previously demonstrated that
Pdcd4 acts as a tumor suppressor in neuroendocrine cells [5, 37]. In-
vestigating the effect of medium containing the secreted peptides
(conditioned medium from shPdcd4 transfected cell lines) on neuro-
endocrine wild type Bon-1 cells we found increased proliferation, col-
ony formation and wound healing, but decreased adhesion of the
cells. Consistent with our data epithelial enhanced expression of
Ang-2 was found in neuroendocrine tumors, and recombinant ex-
pression of Ang-2 in orthotopic Bon-1 xenografts led to increasedmicrovessel density and spread of tumor cells into lymph nodes
showing again the impact of secreted Ang-2 on tumor formation
[38]. Moreover, circulating Ang-2 levels correlated with metastatic
disease in patients with neuroendocrine tumors. Additionally, Ang-2
expression corresponded to lymph node invasion in patients with
non-small cell lung cancer and breast cancer, respectively [39, 40].
Even if down-regulation of Pdcd4 and increased levels of Ang-2
were demonstrated in a variety of tumors, we have shown this corre-
lation in the same cells for the ﬁrst time. All this data stress the im-
portance of Ang-2 regulation in tumor progression, angiogenesis
and metastasis.
A tumor can only proliferate up to the size of 1–2 mm without
vascularization. Neoangiogenesis promotes tumor growth in two
ways: ﬁrstly by supply of nutrients and removal of metabolic waste
products and, secondly, by the accession of neoplastic cells to the
blood vessels, thereby facilitating metastasis. Neovascularization is
tightly regulated and depends on the balance of proangiogenic and
antiangiogenic factors (inducers and suppressors) and deregulation
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tumor formation (for review see [41]). Ang-2 is an interesting modu-
lator of angiogenesis since in the presence of VEGF induction of vessel
formation proceeds whereas in the absence of VEGF vessel regression
occurs (for review see [15]). In addition, Bon-1 cells are known to
produce and secrete high levels of VEGF and, therefore, provide the
growth factors necessary for the proangiogenic effects of Ang-2 [42].
Therefore, we investigated the inﬂuence of conditioned medium notonly on Bon-1 cells but also on an endothelial cell line (HMEC-1).
Though no effect could be shown on proliferation of HMEC-1 cells
most likely due to the fact that the conditioned medium obtained
from transfected Bon-1 and HCT116 cells is improper for growth of
endothelial cells, a slight decrease in adhesion to multiwell plates
coated with conditioned medium was observed. It is well established
that Ang-2 induces a loosening of perivascular and endothelial cells
from the extracellular matrix, thereby disturbing vascular integrity.
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797S. Krug et al. / Biochimica et Biophysica Acta 1823 (2012) 789–799However, a signiﬁcant increase in colony formation and cell migra-
tion induced by the supernatant of shPdcd4 transfected Bon-1 and
HCT116 cells was found.
The observation that the endothelial cell line was affected by the
conditioned medium obtained from Pdcd4 depleted cells prompted
us to study the inﬂuence of this medium on angiogenesis. In fact,
we found enhanced tube formation by treatment of endothelial cells
with conditioned medium from shPdcd4 transfected Bon-1 and
HCT116 cells which was reversed by treatment of the endothelial
cells with medium obtained from cells additionally transfected with
siAng-2 RNA. These data suggests an involvement of Pdcd4 expres-
sion in abnormal vascularization of tumors by affecting Ang-2 expres-
sion and release. Hence, induction of Pdcd4 may offer a newtherapeutic possibility to inhibit cancer growth by suppression of
Ang-2. Supporting this assumption, Ang-2 levels are discussed as an
interesting therapeutic target and as a useful clinical marker for pro-
gression of human cancers (for review see [33]). However, the mech-
anisms of tumor angiogenesis are not completely understood and,
furthermore, the Ang-2 function is cell context dependent. Pdcd4
acts tumor suppressive by affecting not only angiogenesis but also
transcription and translation of proteins involved in cell cycle, differ-
entiation and apoptosis (for review see [1]). Therefore, it certainly
represents an attractive target for future cancer therapy. There is
emerging evidence that Pdcd4 impacts angiogenesis. Aerosol delivery
of Pdcd4 into non-small cell lung cancer model mice (K-ras null)
inhibited angiogenesis and both proangiogenic factors VEGF and
A
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Fig. 8. Impact of conditioned medium from shPdcd4 transfected Bon-1 and HCT116 cell lines on endothelial HMEC-1 cells. A: Cell migration of HMEC-1 cells in Boyden Chamber
assays. Conditioned medium from mock and shPdcd4 transfected Bon-1 and HCT116 cells containing 1% and 10% FBS was used. Stars (☆) represent signiﬁcant p-values
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ined it maybe speculated that its levels were as well reduced by high
amounts of Pdcd4. Furthermore, another study demonstrates that
Ang-2 was over-expressed in non-small cell lung cancer and was as-
sociated with high vascularization [40]. Previously, we have shown
that Pdcd4 knockdown results in enhanced release of secretogranin
II [10]. The Sg II derived peptide secretoneurin can function as a
proangiogenic factor, indicating that Pdcd4 alters angiogenesis by
regulating different proteins.
In the present study, we show for the ﬁrst time that Ang-2 expres-
sion is controlled by Pdcd4 in a wide variety of cell types. This pro-
vides a new mechanism for regulation of Ang-2 and, thereby, for an
inﬂuence on vessel formation. In this context it is of special interest,
that over-expression of Ang-2 promoted metastasis in breast cancer
cells and leads to suppression of E-cadherin, induced Snail expressionand phosphorylation of GSK-3β [44]. Therefore, Ang-2 is not only able
to boost cancer progression by stimulating tumor vessel formation,
but also to convey metastasis. Taken together, even if the functional
network of Ang-2 and tumor microenvironment is not fully under-
stood yet, the regulation of Ang-2 expression by Pdcd4 may provide
a promising target for cancer therapy. It will be most fascinating to
further investigate the complex functions of the tumor suppressor
Pdcd4.5. Conclusions
The tumor suppressor Pdcd4 inﬂuences cancer development,
growth and metastasis by multiple mechanisms. A completely new
mode is the regulation of Ang-2 expression and secretion by Pdcd4
799S. Krug et al. / Biochimica et Biophysica Acta 1823 (2012) 789–799levels. Enhanced Ang-2 release enables neovascularization of tumor
tissues and, thereby, a stimulation of tumor growth can occur.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbamcr.2012.01.006.References
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